Statin use and colorectal adenoma risk: Results from the adenoma prevention with celecoxib trial

Cancer Prevention Research

Volumn 3, Issue 5, 2010, Pages 588-596

  Bertagnolli, Monica M ^a   Hsu, Meier ^c   Hawk, Ernest T ^d   Eagle, Craig J ^b   Zauber, Ann G ^c  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b PFIZER INC   (United States)

^c MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^d UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ATORVASTATIN; CELECOXIB; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; MEVINOLIN; PLACEBO; PRAVASTATIN; SIMVASTATIN;

ADULT; AGED; ANAMNESIS; ARTICLE; CANCER RISK; CARDIOVASCULAR DISEASE; CLINICAL TRIAL; COLONOSCOPY; COLORECTAL ADENOMA; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG USE; FEMALE; HEART PROTECTION; HUMAN; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT; TREATMENT DURATION;

ADENOMA; ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS; CARDIOVASCULAR DISEASES; COLORECTAL NEOPLASMS; FEMALE; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; MALE; MIDDLE AGED; PYRAZOLES; SINGLE-BLIND METHOD; SULFONAMIDES;

EID: 77952071890     PISSN: 19406207     EISSN: None     Source Type: Journal    
DOI: 10.1158/1940-6207.CAPR-09-0271     Document Type: Article

References (24)

1. Demierre M-F, Higgins PD, Gruber SB, Hawk E, Lippman SM. Statins and cancer prevention. Nature 2005;5:930-942
2. Swamy M, Patiolla J, Steele V, Kopelovich L, Reddy B, Rao C. Chemoprevention of familial adenomatous polyposis by low doses of atorvastatin and celecoxib given individually and in combination to APC Min mice. Cancer Res 2006;66:7370-7377 (Pubitemid 44197721)
3. Reddy B, Wang C, Kong A, et al. Prevention of azoxymethaneinduced colon cancer by combination of low doses of atorvastatin, aspirin, and celecoxib in F344 rats. Cancer Res 2006;66:4542-4546
4. Rossebo AB, Pedersen TR, Bowman K, et al. Intensive lipid lowering with simvastatin and ezetimibe in aortic stenosis. N Engl J Med 2008; 359:1343-1356
5. Oliver M. Might treatment of hypercholesterolaemia increase noncardiac mortality. Lancet 1991;337:1529-1531
6. Shepherd J, Blauw GJ, Murphy MB, et al. Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomized controlled trial. Lancet 2002;360:1623-1630 (Pubitemid 35379733)
7. Alsheikh-Ali AA, Karas RH. The relationship of statins to rhabdomyolysis, malignancy, and hepatic toxicity: evidence from clinical trials. Curr Atheroscler Rep 2009;11:100-104
8. Thompson JS, Sood A, Arora R. Statins and cancer: a potential link? Am J Ther. Epub 2009 May 18.
9. Poynter JN, Gruber SB, Higgins PD, et al. Statins and the risk of colorectal cancer. N Engl J Med 2005;352:2184-2192
10. Hoffmeister M, Chang-Claude JMB. Individual and joint use of statins and low-dose aspirin and risk of colorectal cancer: a populationbased case-control study. Int J Cancer 2007;121:1325-1330 (Pubitemid 47293801)
11. Setoguchi S, Glynn RJ, Avorn J, Mogun H, Schneeweiss S. Statins and the risk of lung, breast, and colorectal cancer. Circulation 2007;115:27-33. (Pubitemid 46058608)
12. Jacobs EJ, Rodriguez C, Brady KA, Connell CJ, Thun MJ, Eugenia EC. Cholesterol-lowering drugs and colorectal cancer incidence in a large United States cohort. J Natl Cancer Inst 2006;98:69-72. (Pubitemid 43057094)
13. Coogan PF, Smith J, Rosenberg L. Statin use and risk of colorectal cancer. J Natl Cancer Inst 2007;99:32-40. (Pubitemid 46263361)
14. Vinogradova Y, Hippisley-Cox J, Coupland C, Logan RF. Risk of colorectal cancer in patients prescribed statins, nonsteroidal anti-inflammatory drugs, and cyclooxygenase-2 inhibitors: nested casecontrol study. Gastroenterology 2007;133:393-402. (Pubitemid 47187349)
15. Friedman GD, Flick ED, Udaltsova N, Chan J, Quesenberry CP, Habel LA. Screening statins for possible carcinogenic risk: up to 9 years of follow-up of 361859 recipients. Pharmacoepidemiol Drug Saf 2008;17:27-36. (Pubitemid 351166615)
16. Haukka J, Sankila R, Klaukka T, et al. Incidence of cancer and statin usage - record linkage study. Int J Cancer 2009;126:279-284
17. Bonovas S, Filioussi K, Flordellis CS, Sitaras N. Statins and the risk of colorectal cancer: a meta-analysis of 18 studies involving more than 1.5 million patients. J Clin Oncol 2007;25:3462-3468 (Pubitemid 47310884)
18. Siddiqui AA, Nazario H, Mahgoub A, Pandove S, Cipher D, Spechler SJ. The long-term use of statins is associated with a decreased incidence of adenomatous colon polyps. Digestion 2009;79:17-22.
19. Siddiqui A, Nazario H, Patel M, Mahgoub A, Spechler SJ. Reduction in low-density lipoprotein cholesterol levels during statin therapy is associated with a reduced incidence of advanced colon polyps. Am J Med Sci 2009;338:378-381
20. Wei JT, Mott LA, Baron JA, Sandler RS, Group. at PP. Reported use of 3-hydroxy-3-methylated coenzyme a reductase inhibitors was not associated with reduced recurrence of colorectal adenomas. Cancer Epidemiol Biomarkers Prev 2005;14:1026-7.
21. Bertagnolli M, Eagle C, Zauber A, et al. Prevention of sporadic colorectal adenomas with celecoxib: results of a randomized trial. N Engl J Med 2006;355:873-884
22. Solomon S, McMurray J, Pfeffer M, et al. Cardiovascular risk associated with celecoxib in a clinical trial for adenoma prevention. N Engl J Med 2005;352:1071-1080 (Pubitemid 40365348)
23. Bertagnolli M, Eagle C, Zauber A, et al. Year 5 efficacy and safety analysis of the Adenoma Prevention with Celecoxib (APC) Trial. Cancer Prev Res 2009;2:310-321
24. D'Agostino RB. Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group. Stat Med 1998;17:2265-2281